Study: VEGF-A modified RNA helps convert cardiac cells into blood vessels

09/11/2013 | San Diego Union-Tribune

Researchers from Harvard University and Karolinska Institute in Stockholm converted cardiac stem cells into blood vessels using synthetic messenger RNA in the damaged hearts of mice. The study in Nature Biotechnology shows the potential of using modified RNA that codes for the protein VEGF-A in the development of new heart tissue. AstraZeneca and Moderna Therapeutics are working to develop the approach for use in patients.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC